Elequin Capital’s Tenet Healthcare THC Stock Holding History

Elequin Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-254	Closed	-$42.2K	–	626
2024 Q3	$42.2K	Buy	254 +52	+26%	+$7.86K	﹤0.01%	72
2024 Q2	$26.9K	Buy	+202	New	+$24.3K	0.01%	50

Other funds holding THC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Elequin Capital's THC Position: Q4 2024 in Review

Elequin Capital sold out of Tenet Healthcare (THC) in Q4 2024, closing a stake of 254 shares — an estimated $42.2K sold.

Elequin Capital first reported a position in THC in Q2 2024 and held it in 2 quarters. The position peaked at $42.2K in Q3 2024. 577 funds tracked by Wall St. Rank hold THC as of Q4 2024.

Elequin Capital reported no remaining Tenet Healthcare position as of Q4 2024 after selling out during the quarter.
Elequin Capital sold 254 Tenet Healthcare shares in Q4 2024, an estimated $42.2K.
Elequin Capital first reported a position in Tenet Healthcare in Q2 2024 and held it in 2 quarters.
Elequin Capital's Tenet Healthcare position peaked at $42.2K in Q3 2024.
577 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.

Based on Elequin Capital's 13F filing for Q4 2024, filed 18 Feb 2025.